Home  >  News
  AstraZeneca's hyperkalaemia drug, ZS-9 gets positive opinion from EMA committee,   February 27, 2017
  EMA committee recommends approval of Novartis' Tafinlar + Mekinist in BRAF-positive NSCLC patients,   February 27, 2017
  US FDA issues draft norms for difluprednate, an ophthalmic emulsion to treat eye swelling and pain,   February 27, 2017
  Avella recalls all sterile products produced at Advanced Pharma Houston location from Sept 1, 2016 through Feb 16, 2017 due to potential inaccuracy of latex free label reference,   February 25, 2017
  Standards Council of Canada issues GLP certification to Certara's CSC Montreal facility,   February 24, 2017
  US FDA grants priority review status to Novartis' drug Zykadia to treat patients with ALK+ metastatic NSCLC,   February 24, 2017
  Biolabexs launches first R&D laboratory in BioPark Mauritius,   February 24, 2017
  US FDA grants fast track designation to Cell Medica’s lead oncology product CMD-003,   February 23, 2017
  Amgen’s Repatha receives European approval for new 420 mg single-dose delivery option,   February 23, 2017
  Daiichi Sankyo joins business network, “IkuBoss Alliance”,   February 23, 2017
  US FDA accepts and grants priority review status to Pfizer's BLA for inotuzumab ozogamicin,   February 22, 2017
  MedPlast to buy Vention Medical’s device manufacturing business,   February 22, 2017
  Henry Schein to buy US-based anesthesia, surgical distributor Southern Anesthesia + Surgical,   February 21, 2017
  Mereo BioPharma's BPS-804 accepted for EMA adaptive pathways programme,   February 21, 2017
  US FDA approves Perrigo's hydrocodone bitartrate & homatropine methylbromide oral solution,   February 20, 2017
  Ethicon to buy medical device company, Torax Medical,   February 20, 2017
  Capricor Therapeutics cancels license pact with Mayo Clinic relating to natriuretic peptide receptor agonists including Cenderitide,   February 18, 2017
  BTG, SIO collaborate to explore role of minimally invasive therapies in immuno-oncology,   February 18, 2017
  US FDA approves expanded indication for Boehringer Ingelheim’s asthma drug, Spiriva Respimat,   February 17, 2017
  Takeda acquires Ariad Pharma for $24 per share,   February 17, 2017

Pharma Project Management 2017
Copyright © 2016 Saffron Media Pvt. Ltd |